iohexol has been researched along with Response Evaluation Criteria in Solid Tumors in 4 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Response Evaluation Criteria in Solid Tumors: An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve, worsen, or remain stable during treatment. These criteria are based specifically on the response of the tumor(s) to treatment, and not on the overall health status of the patient resulting from treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, S | 1 |
| Fuld, MK | 1 |
| Laheru, D | 1 |
| Huang, P | 1 |
| Fishman, EK | 1 |
| Zhang, L | 1 |
| Wang, N | 1 |
| Mao, J | 1 |
| Liu, X | 1 |
| Gao, Z | 1 |
| Dai, X | 1 |
| Feng, B | 1 |
| Thian, Y | 1 |
| Gutzeit, A | 1 |
| Koh, DM | 1 |
| Fisher, R | 1 |
| Lote, H | 1 |
| Larkin, J | 1 |
| Sohaib, A | 1 |
| Yip, C | 1 |
| Tacelli, N | 1 |
| Remy-Jardin, M | 1 |
| Scherpereel, A | 1 |
| Cortot, A | 1 |
| Lafitte, JJ | 1 |
| Wallyn, F | 1 |
| Remy, J | 1 |
| Bassett, P | 1 |
| Siddique, M | 1 |
| Cook, GJ | 1 |
| Landau, DB | 1 |
| Goh, V | 1 |
1 review available for iohexol and Response Evaluation Criteria in Solid Tumors
| Article | Year |
|---|---|
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.
Topics: Adenocarcinoma; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Contrast Media; Fe | 2018 |
3 other studies available for iohexol and Response Evaluation Criteria in Solid Tumors